secwatch.observer — SEC 8-K summary
======================================

Issuer:     Editas Medicine, Inc. (EDIT)
CIK:        0001650664
Form:       8-K
Filed at:   2025-03-20T23:59:59+00:00
Accession:  0001650664-25-000031
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Editas Medicine CFO resigns; Amy Parison appointed as CFO
---------------------------------------------------------

- Erick Lucera resigns as EVP, CFO effective March 28, 2025.
- Amy Parison, previously SVP Finance, appointed SVP, CFO and Treasurer effective March 28, 2025.
- Parison receives $415k base salary, 40% target bonus, and option for 34,672 shares vesting monthly over 4 years.
- Parison joined Editas in Aug 2022 as VP Finance, Corporate Controller, promoted to SVP Finance Jan 2025.
- No arrangement or understanding behind Parison's selection; no reportable transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1650664/000165066425000031/0001650664-25-000031-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1650664/000165066425000031/edit-20250318.htm
  HTML page:      https://secwatch.observer/filing/0001650664-25-000031

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer